Reprint
Clinical Prognostic and Predictive Biomarkers
Edited by
March 2024
320 pages
- ISBN978-3-7258-0587-7 (Hardback)
- ISBN978-3-7258-0588-4 (PDF)
This book is a reprint of the Special Issue Clinical Prognostic and Predictive Biomarkers that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
In this Special Issue, we finally included 20 papers, focused on multiple clinical diseases, including cancers, infectious diseases (COVID-19, pancreatitis, etc.), autoimmune diseases, and metabolic diseases. In terms of the types of biomarkers, they include non-coding RNA, inflammatory factors, cytokines, etc. These papers have explored the clinical biomarkers in diagnosis, risk stratification, treatment response, and prognosis assessment in their respective fields, which is of great significance for the clinical management and future research pertaining to these diseases.
Format
- Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
preeclampsia; hypertension; hormones; postpartum; serum; emergency department; triage; COVID-19 biomarkers; mid-regional proadrenomedullin; neutrophil; CD64 index; acute pancreatitis; abdominal infection; cervical cancer; pelvic lymph node metastasis; radiomics; nomogram; cardiotoxicity; chemotherapy; breast cancer; speckle tracking; biomarkers; kazakhstan; gastrointestinal stromal tumor; prediction; response monitoring; FDG-PET; radiomics; tomography; X-ray computed; personalized medicine; isocitrate dehydrogenase; Ollier disease; Maffucci syndrome; cartilage tumour; extraskeletal neoplasms; haemangioma; paediatric ovarian tumour; genetic algorithm; machine learning; metabolites; type 2 diabetes; immune-related lncRNA; ddPCR; prognosis; immunotherapy; lung adenocarcinoma; biomarkers; bronchoalveolar lavage fluid; lung neoplasm; tumor microenvironment; Nectin; Necl; cancer; colorectal; diagnostics; Clostridioides difficile; inflammatory bowel disease; PCT; CRP; WBC; PASC; long COVID; pulmonary function tests; brain imaging; chest imaging; COVID symptoms; fatigue; shortness of breath; miRNAs; SARS-CoV-2; immune response; antimicrobial resistance; sepsis; early diagnosis; conventional methods; modern methods; advanced methods; Perthes disease; candidate genes; biomarkers; biological therapy; hepatocellular carcinoma; PIVKA-II; AFP; nomogram; diagnosis; prognosis; gene expression; prognosis; prediction; score; mesothelioma; mRCCs; late-line treatment; prognostic factors; risk classification; chronic subdural hematoma; prognosis; recurrence; biomarker